Niu Xin, Zhang Lei, Wu Yuchen, Zong Zhi, Wang Bin, Liu Jisheng, Zhang Long, Zhou Fangfang
Department of Otolaryngology Head and Neck Surgery The First Affiliated Hospital of Soochow University Suzhou China.
MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network Life Sciences Institute Zhejiang University Hangzhou China.
MedComm (2020). 2023 Feb 28;4(2):e223. doi: 10.1002/mco2.223. eCollection 2023 Apr.
Biomolecular condensates are cellular structures composed of membraneless assemblies comprising proteins or nucleic acids. The formation of these condensates requires components to change from a state of solubility separation from the surrounding environment by undergoing phase transition and condensation. Over the past decade, it has become widely appreciated that biomolecular condensates are ubiquitous in eukaryotic cells and play a vital role in physiological and pathological processes. These condensates may provide promising targets for the clinic research. Recently, a series of pathological and physiological processes have been found associated with the dysfunction of condensates, and a range of targets and methods have been demonstrated to modulate the formation of these condensates. A more extensive description of biomolecular condensates is urgently needed for the development of novel therapies. In this review, we summarized the current understanding of biomolecular condensates and the molecular mechanisms of their formation. Moreover, we reviewed the functions of condensates and therapeutic targets for diseases. We further highlighted the available regulatory targets and methods, discussed the significance and challenges of targeting these condensates. Reviewing the latest developments in biomolecular condensate research could be essential in translating our current knowledge on the use of condensates for clinical therapeutic strategies.
生物分子凝聚物是由包含蛋白质或核酸的无膜聚集体组成的细胞结构。这些凝聚物的形成需要组分通过经历相变和凝聚从与周围环境处于溶解分离的状态转变。在过去十年中,人们已普遍认识到生物分子凝聚物在真核细胞中普遍存在,并在生理和病理过程中发挥重要作用。这些凝聚物可能为临床研究提供有前景的靶点。最近,已发现一系列病理和生理过程与凝聚物功能障碍相关,并且已证明一系列靶点和方法可调节这些凝聚物的形成。为开发新疗法,迫切需要对生物分子凝聚物进行更广泛的描述。在本综述中,我们总结了目前对生物分子凝聚物的认识及其形成的分子机制。此外,我们综述了凝聚物的功能和疾病的治疗靶点。我们进一步强调了可用的调控靶点和方法,讨论了靶向这些凝聚物的意义和挑战。回顾生物分子凝聚物研究的最新进展对于将我们目前关于凝聚物用于临床治疗策略的知识转化应用可能至关重要。